🔗 Share this article

An underground economy for unapproved slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Experimental Drug Gaining Traction Online

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Followers are encouraged to message these accounts directly for supplier links, while also receiving discount codes.

Active Commerce on Social Networks

Additionally, a robust trade exists on messaging services, where groups with thousands of participants share “before and after” photos, injection guides and claims of rapid British shipping. Sellers market the drug there before redirecting customers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Professionals Voice Worries

Nevertheless, physicians and pharmacists have warned that the distribution of what remains an unapproved medication in the United Kingdom is worrisome and could lead to individuals injecting substances of unknown origin.

Several professionals stated the popularity for retatrutide could be linked to the rising cost of approved slimming treatments such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that cannot be promoted or distributed for personal consumption under the British medical regulations.

Several content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still violate medicines, advertising, and customer laws, risking penalties, prosecution or imprisonment.

Service Response and Content Removal

According to the social media company, the platform has taken down violative material and prohibited associated hashtags and search suggestions. The organization stated it was dedicated to keeping the platform secure and investing in enhancing enforcement strategies.

Digital Marketplace Activities

Investigations also found communities with up to nine thousand members marketing retatrutide using Telegram's integrated discovery tool, which functions like a public directory. Typing “retatrutide” instantly brings up groups with thousands of users, populated with images of slimming results, glowing testimonials and step-by-step instructions for mixing or administering at residence.

After minutes of joining one community, a seller posted contact information, where the majority of transactions occur. The seller sent an instruction manual and promised shipping within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one asked about body mass, health issues or previous experience.

Item Details and Pricing

Inside these groups, posts show black plastic packages with postal service labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20mg. When questioned how long a pen should last, sellers give contradictory responses ranging from a several days to “depends on your body”.

Platform Oversight and Safety Measures

A representative for the messaging service said it actively monitored harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are administering substances they cannot confirm. Although the science behind this drug is valid, these digital products may not contain what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current price rises for approved slimming medications such as Mounjaro. “With prices rising, individuals are turning to social media. But fake treatments are highly dangerous. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said.

Her team has already encountered patients injured by personal administration from unverified suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be impure or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company experimental product not yet authorized … may subject patients to potentially significant medical dangers”.